Use of cell-based screening to identify small-molecule compounds that modulate claudin-4 expression

Area of Science:

• Molecular Biology
• Cell Biology
• Pharmacology

Background:

• Claudins are integral membrane proteins crucial for tight junction integrity in epithelial tissues.
• Claudin-4 expression is dysregulated in inflammatory bowel disease (IBD) and human cancers, making it a potential therapeutic target.
• Previous work established a reporter cell line to track claudin-4 promoter activity.

Purpose of the Study:

• To identify small-molecule compounds that modulate claudin-4 expression.
• To discover potential therapeutic agents for diseases associated with aberrant claudin-4 levels, such as IBD.

Main Methods:

• A cell-based screen of 2642 biologically active small-molecule compounds was conducted.
• A reporter cell line, based on a functional claudin-4 promoter, was utilized to monitor gene expression.
• Compounds were assessed for their ability to modulate claudin-4 promoter activity.

Main Results:

• The screen identified 24 potential modulators of claudin-4 promoter activity.
• Fourteen of these compounds, including 12 novel ones, successfully induced endogenous claudin-4 expression.
• These compounds demonstrated efficacy in modulating the target gene's expression.

Conclusions:

• The identified small molecules represent promising lead compounds for targeting claudin-4.
• These compounds may offer a novel therapeutic strategy for inflammatory bowel disease and other conditions linked to claudin-4 dysregulation.
• Further investigation into these modulators could lead to new treatments.